3/31/2011

The FDA approved Aurobindo Pharma's version of Razadyne, Ortho-McNeil-Janssen Pharmaceuticals' oral treatment for Alzheimer's disease. The generic, galantamine, will be marketed in doses of 4, 8 and 12 milligrams.

Related Summaries